192 related articles for article (PubMed ID: 12040282)
1. Long-term follow-up of patients with conjunctival melanoma.
Werschnik C; Lommatzsch PK
Am J Clin Oncol; 2002 Jun; 25(3):248-55. PubMed ID: 12040282
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.
Lommatzsch PK; Lommatzsch RE; Kirsch I; Fuhrmann P
Br J Ophthalmol; 1990 Oct; 74(10):615-9. PubMed ID: 2285686
[TBL] [Abstract][Full Text] [Related]
3. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
9. [Pathology and prognostic factors of conjunctival melanoma].
Berta-Antalics AI; Kruse FE; Holbach L
Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
[TBL] [Abstract][Full Text] [Related]
10. [Combined surgery, cryocoagulation and radiotherapy for treatment of melanoma of the conjunctiva].
Zografos L; Uffer S; Bercher L; Gailloud C
Klin Monbl Augenheilkd; 1994 May; 204(5):385-90. PubMed ID: 8051878
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
12. Proton radiotherapy in advanced malignant melanoma of the conjunctiva.
Scholz SL; Hérault J; Stang A; Griewank KG; Meller D; Thariat J; Steuhl KP; Westekemper H; Sauerwein W
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1309-1318. PubMed ID: 30919076
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study.
Anastassiou G; Heiligenhaus A; Bechrakis N; Bader E; Bornfeld N; Steuhl KP
Br J Ophthalmol; 2002 Feb; 86(2):163-7. PubMed ID: 11815341
[TBL] [Abstract][Full Text] [Related]
14. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
15. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
17. [Treatment modalities for conjunctival melanoma].
Krause L; Mladenova A; Bechrakis NE; Kreusel KM; Plath T; Moser L; Foerster M
Klin Monbl Augenheilkd; 2009 Dec; 226(12):1012-6. PubMed ID: 20108195
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].
Heindl LM; Koch KR; Schlaak M; Mauch C; Cursiefen C
Ophthalmologe; 2015 Nov; 112(11):907-11. PubMed ID: 26502167
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival melanoma: pitfalls and dilemmas in management.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2010 Sep; 21(5):380-6. PubMed ID: 20531189
[TBL] [Abstract][Full Text] [Related]
20. [Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma].
Kimura K; Usui Y; Goto H
Nippon Ganka Gakkai Zasshi; 2012 May; 116(5):503-9. PubMed ID: 22690541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
